Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by T.P. Markova
Total Records ( 1 ) for T.P. Markova
  T.P. Markova , Y. Aragane , A. Niwa , M. Tabuchi , M. Orita , K. Ooshima and H. Higashino
  Phosphodiesterases (PDE) catalyze the breakdown of cAMP and thus, may have potent immunomodulatory activity. Theophyllin is a non-selective PDE inhibitor and has long been used to treat atopic diseases such as asthma, based on its well-known effects of the bronchodilative and anti-inflammatory effects, although the immune modulatory activities are not completely clear yet. Because it is believed that Th2-immnuity plays a pathogenic role in asthma, we were interested to study the mechanisms of how it modulates mite-allergen-induced activation of Th2-like immunity. To address this issue, peripheral blood mononuclear cells (PBMC) were prepared from human healthy volunteers, stimulated with mite-allergen dermatophagoides farinae (Der-f), RNA prepared and semi-quantitative RT-PCR was performed using primers specific for IL-5, a representative Th2 cytokine. Consequently, it was found that theophylline at a concentration of 10-6 to 10-5 M significantly downregulated Der-f-induced expression of IL-5 mRNA. Intriguingly, theophylline (10-5 M) inhibited the expression of IL-5 mRNA of PBMCs from patients allergic to house dust mite. To further explore the mechanisms involved, a PKA type I inhibitor Rp-8-Br-cAMPS was added, resulting in restoration of theophylline-downregulated expression of Der-f-induced IL-5 mRNA, indicating the involvement of PKA in this event. Together, the present study demonstrates that theophylline prevents allergen-induced PKA activation and thus may, at least in part, inhibit Th2-like immune responses.
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility